Travere Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Travere Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.9M | 212k | 9.00 |
| 2023-09-30 | $3.0M | 333k | 8.94 |
| 2023-03-31 | $8.1M | 362k | 22.49 |
| 2022-12-31 | $3.1M | 145k | 21.03 |
| 2022-09-30 | $4.7M | 191k | 24.64 |
| 2021-12-31 | $4.5M | 144k | 31.04 |
| 2021-03-31 | $3.0M | 125k | 24.17 |
| 2020-12-31 | $331k | 12k | 27.44 |